APOG vs MATW

APOG exhibits exceptional financial health with a Piotroski F-Score of 8/9, indicating strong operational efficiency and balance sheet stability. While the current price of $38.29 is slightly above the Graham Number ($31.86), it trades at a significant discount to its growth-based intrinsic value of $55.17 and a very attractive forward P/E of 10.73. Despite stagnant revenue growth and a bearish technical trend, the company's consistent track record of earnings beats and conservative debt-to-equity ratio (0.56) provide a strong margin of safety. The combination of deep value and high deterministic health makes this a compelling long-term play.

MATW exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a current price ($27.07) that significantly exceeds both its Graham Number ($16.70) and Intrinsic Value ($4.97). The company is facing a crisis in growth with revenue declining by 29.10% YoY and operating margins turning negative (-4.53%). Furthermore, the dividend is unsustainable with a payout ratio of 141.55%, indicating a high risk of a dividend cut. Despite bullish analyst targets, the deterministic data suggests a value trap scenario.